Abraham G. Hartzema

Abraham G. Hartzema PharmD, MSPH, PhD, FISPE Professor, Perry A. Foote Eminent Scholar Chair in Health Outcomes and Pharmacoeconomics University of Florida, School of Pharmacy BS, Pharmacy, University of Utrecht MSPH, University of Washington PharmD, University of Utrecht PhD, Social and Administrative Pharmacy, University of Minnesota

Dr. Hartzema's research interests are health outcomes research with an emphasis on pharmacoepidemiology, risk management, economics, program evaluation, and health services research. He has served as principal and co-investigator on major grants from the National Institutes of Health, government entities, foundations and the pharmaceutical industry. He has co-authored and edited three books, two of which are in multiple editions, two monographs, one of which is translated in several languages, and has published and presented more than 100 chapters, journal articles, abstracts and presentations.

SELECTED PUBLICATIONS:

Books:

• Hartzema AG, Porta MS, and Tilson HM, editors. Pharmacoepidemiology: An Introduction, Harvey Whitney Books, Cincinnati, Ohio, 1988 - Second Edition, 1991; Third Edition, 1999; Fourth Edition forthcoming.
• Hartzema AG, Mullins, DC, Pharmaceutical Chartbook, The Haworth Press, Binghamton, NY, 1995.

Chapters, Articles, Chapters, Reports:

• Shih YCT, Hartzema AG, Tolleson-Rinehart S. Labor Costs of incontinence care in long-term care (accepted Urology).
• Kettis Lindblad A, Hartzema AG, Jansson L, Feltelius N. Patients' views of priority setting for new medications: a qualitative study of patients with rheumatoid arthritis. Scandanavian Journal of Rheumatology 2002; 31:324-9.
• Grabenstein JD, Guess HA, Hartzema AG, Koch GG, Konrad TR. Attitudinal factors among adult prescription pecipients associated with choice of where to be vaccinated. Journal of Clinical Epidemiology 2002; 55:279-284.
• Grabenstein JD, Hartzema AG, Gues HA, Koch GG, Konrad TR. Effect of vaccination by community pharmacists among adult prescription recipients. Medical Care 2001; 39:340-8.
• Pradel F, Hartzema AG, Bush PJ. Children with asthma use of inhalation devices: techniques, autonomy and perception of ease of use. Journal for Social and Administrative Pharmacy 2001; 18: 178-184.
• Pradel F, Hartzema AG, Bush PJ. Asthma selfmanagement: The perspective of childern. Patient Education and Counseling. 2001; 1486:1-14.
• Grabenstein JD, Guess H, Hartzema AG. People vaccinated by community pharmacists: Descriptive Epidemiology. J Am Pharm Assoc 2001;41:46-52.
• Hartzema AG, Day RS, Tolleson-Rinehart S, Sleath B, Bush PJ. Optimizing patient comprehension through medicine information leaflets. Final Report. United States Pharmacopeia, 1999.
• Huang X, Hartzema AG, Kauf TL, Norwood GJ, Raasch RH. The economic evaluation of antimicrobial therapy for uncomplicated urinary tract infection in women. Clinical Therapeutics. 1999; 21:1578-1588.
• Pradel FG, Hartzema AG, Mutran E, Hanson-Divers C. Physician's over the counter drug prescribing patterns; An analysis of the National Ambulatory Medical Care Survey. Annals of Pharmacotherapy 1999; 33:400-5.
• Almarsdottir AB, Hartzema AG, Bush PJ, Simpson KN, Zimmer C. Childrens' attitudes and beliefs about illness and medicines. A triangulation of open-ended and semi-structured interviews. J Social Admin Pharmacy 1997; 14:26-41.
• West SL, Savitz SL, Koch G, Sheff KL, Thom BL, Guess HA, Hartzema AG. Demographics, health behaviors, and past drug use as predictors of recall accuracy for previous prescription medication use. Journal of Clinical Epidemiology. 1997; 50(8):975-80.
• Hartzema AG. Foreward to Standards for Economic Evaluation of Drugs. Medical Care, 1996; 125:1-2.
• Sirpa W, Kirsti V, Korhonen M, Hartzema AG, Euland H. Self-initiated modification of hypertension treatment in response to perceived problems. Annals of Pharmacotherapy 1995; 29:1213-7.